[go: up one dir, main page]

AU2002350409A1 - Surfactant protein-d and atherosclerosis - Google Patents

Surfactant protein-d and atherosclerosis

Info

Publication number
AU2002350409A1
AU2002350409A1 AU2002350409A AU2002350409A AU2002350409A1 AU 2002350409 A1 AU2002350409 A1 AU 2002350409A1 AU 2002350409 A AU2002350409 A AU 2002350409A AU 2002350409 A AU2002350409 A AU 2002350409A AU 2002350409 A1 AU2002350409 A1 AU 2002350409A1
Authority
AU
Australia
Prior art keywords
atherosclerosis
surfactant protein
surfactant
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350409A
Inventor
Uffe Holmskov
Grith Lykke Lyster
Jens Madsen
Ida Tornoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002350409A1 publication Critical patent/AU2002350409A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002350409A 2001-10-26 2002-10-25 Surfactant protein-d and atherosclerosis Abandoned AU2002350409A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33066401P 2001-10-26 2001-10-26
US60/330,664 2001-10-26
US34237201P 2001-12-27 2001-12-27
US60/342,372 2001-12-27
PCT/DK2002/000711 WO2003035683A2 (en) 2001-10-26 2002-10-25 Surfactant protein-d and atherosclerosis

Publications (1)

Publication Number Publication Date
AU2002350409A1 true AU2002350409A1 (en) 2003-05-06

Family

ID=26987389

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350409A Abandoned AU2002350409A1 (en) 2001-10-26 2002-10-25 Surfactant protein-d and atherosclerosis

Country Status (2)

Country Link
AU (1) AU2002350409A1 (en)
WO (1) WO2003035683A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7551496B2 (en) 2017-10-31 2024-09-17 カリヴィル イムノセラピューティクス， インコーポレイテッド Platform oncolytic vectors for systemic delivery
WO2022109133A1 (en) 2020-11-19 2022-05-27 Kalivir Immunotherapeutics, Inc. Oncolytic immunotherapy by tumor micro-environment remodeling
WO2022232375A1 (en) 2021-04-30 2022-11-03 Kalivir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression
JP2024523314A (en) * 2021-06-17 2024-06-28 カリヴィル イムノセラピューティクス， インコーポレイテッド TNFSF-L fusion proteins and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2249354A1 (en) * 1996-03-28 1997-10-02 Genitrix, L.L.C. Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
WO1999050286A2 (en) * 1998-03-31 1999-10-07 University Of Cincinnati Antioxidant peptides derived from apolipoprotein a-iv
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties

Also Published As

Publication number Publication date
WO2003035683A3 (en) 2004-03-04
WO2003035683A2 (en) 2003-05-01
WO2003035683A8 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002306870A1 (en) Pdstudio design system and method
AU2001231682A1 (en) Surfactant combination
AU2001294835A1 (en) Video processing
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2001270792A1 (en) Surfactant
AU2002212839A1 (en) Surveillance arrangement and controller
AU2002353470A1 (en) Online television messenger
AUPR890201A0 (en) Methods and systems (npw005)
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002359694A1 (en) Compounds and methods
AU2002350409A1 (en) Surfactant protein-d and atherosclerosis
AU2002306887A1 (en) Graphics-protection sheet and graphics-displaying sheet
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002352407A1 (en) Video processing
AU2002225190A1 (en) Anticoagulants and their uses
AU2002359869A1 (en) Pak5-related compositions and methods
AUPR838001A0 (en) Dedagging implement and rotor thereof
AU2002308667A1 (en) Complementary iii-v structures and devices
HK1067301A (en) Surfactant compounds and uses thereof
AU2000224661A1 (en) Grill
AU2002345932A1 (en) Compositions and methods for treating atherosclerosis
WO2002099718A8 (en) Configuration systems and methods
AU2001237164A1 (en) Caspase-inhibitory-factor (cif) and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase